Page last updated: 2024-11-06

9-hydroxymethylanthracene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

9-hydroxymethylanthracene: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID73848
CHEMBL ID3188668
SCHEMBL ID59671
MeSH IDM0142007

Synonyms (51)

Synonym
nsc 241166
9-anthrylmethanol
9-(hydroxymethyl)anthracene
brn 1873402
anthracene-9-carbinol
einecs 215-998-5
ccris 7297
unii-2n7uvx2hlm
2n7uvx2hlm ,
9-hydroxymethylanthracene
9-anthracenemethanol ,
9-hydroxymethylantracene
nsc241166
1468-95-7
nsc-241166
9-anthrylcarbinol
9-methylolanthracene
9-anthracenemethanol, 97%
STK387951
anthracen-9-ylmethanol
AC-5807
inchi=1/c15h12o/c16-10-15-13-7-3-1-5-11(13)9-12-6-2-4-8-14(12)15/h1-9,16h,10h2
jcjnnhdztlrsgn-uhfffaoysa-
AKOS000312312
H0670
A808564
9-anthrylmethanol;9-anthracenemethanol
cas-1468-95-7
tox21_202965
dtxcid3029077
NCGC00260511-01
dtxsid1049221 ,
FT-0621620
SCHEMBL59671
9-anthacenemethanol
anthracen-9-yl-methanol
9-anthracene methanol
SY011473
mfcd00001264
Z235448428
9-anthracene carbinol
9-anthrylmethanol #
W-108120
CHEMBL3188668
CS-W019652
AS-12086
AMY11194
(anthracen-9-yl)methyl alcohol
9-anthracenylmethyl alcohol
EN300-7390484
(anthracen-9-yl)methanol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (21)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency71.26950.007215.758889.3584AID1224835
RAR-related orphan receptor gammaMus musculus (house mouse)Potency29.87190.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency72.87550.000714.592883.7951AID1259392
AR proteinHomo sapiens (human)Potency10.81990.000221.22318,912.5098AID1259243; AID1259247; AID743035
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency11.58000.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency54.64890.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency43.39060.003041.611522,387.1992AID1159552; AID1159553; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency64.30980.001530.607315,848.9004AID1224841; AID1224848; AID1224849; AID1259401; AID1259403
pregnane X nuclear receptorHomo sapiens (human)Potency48.70590.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency38.00650.000229.305416,493.5996AID1259244; AID1259248; AID743069; AID743075; AID743078; AID743079; AID743091
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency27.64020.001024.504861.6448AID743212
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency0.00160.001019.414170.9645AID743191
aryl hydrocarbon receptorHomo sapiens (human)Potency23.04530.000723.06741,258.9301AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency30.73140.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency66.25740.001628.015177.1139AID1224843; AID1224895
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency28.43030.057821.109761.2679AID1159526; AID1159528
Histone H2A.xCricetulus griseus (Chinese hamster)Potency50.66180.039147.5451146.8240AID1224845
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency68.79890.000323.4451159.6830AID743067
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency52.36310.000627.21521,122.0200AID743202; AID743219
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency30.73140.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency30.73140.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (12.50)18.7374
1990's4 (50.00)18.2507
2000's0 (0.00)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.37 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index20.59 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]